Novel Therapies for Biofilm-Based Candida spp. Infections.

[1]  H. Bujdáková,et al.  Impact of Farnesol as a Modulator of Efflux Pumps in a Fluconazole-Resistant Strain of Candida albicans. , 2019, Microbial drug resistance.

[2]  L. Brugnoni,et al.  Effect of quorum sensing molecules and natamycin on biofilms of Candida tropicalis and other yeasts isolated from industrial juice filtration membranes , 2019, Journal of applied microbiology.

[3]  M. Pourhajibagher,et al.  Antimicrobial efficacy of photodynamic therapy using two different light sources on the titanium-adherent biofilms of Aggregatibacter actinomycetemcomitans: An in vitro study , 2019, Photodiagnosis and Photodynamic Therapy.

[4]  M. Vatanpour,et al.  The comparison of intracanal medicaments, diode laser and photodynamic therapy on removing the biofilm of Enterococcus faecalis and Candida albicans in the root canal system (ex-vivo study). , 2019, Photodiagnosis and photodynamic therapy.

[5]  R. Hay,et al.  Species distribution and epidemiological characteristics of superficial fungal infections in Southeastern Serbia , 2019, Mycoses.

[6]  R. Šafránek,et al.  In vitro comparison of efficacy of catheter locks in the treatment of catheter related blood stream infection. , 2019, Clinical nutrition ESPEN.

[7]  Amber L. Doiron,et al.  Pyruvate-depleting conditions induce biofilm dispersion and enhance the efficacy of antibiotics in killing biofilms in vitro and in vivo , 2019, Scientific Reports.

[8]  Y. Ghasemi,et al.  Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications , 2019, Foods.

[9]  C. Seneviratne,et al.  Hydrophobicity of graphene as a driving force for inhibiting biofilm formation of pathogenic bacteria and fungi. , 2019, Dental materials : official publication of the Academy of Dental Materials.

[10]  Q. Cheng,et al.  Synergistic in vitro effects of indocyanine green and ethylenediamine tetraacetate-mediated antimicrobial photodynamic therapy combined with antibiotics for resistant bacterial biofilms in diabetic foot infection. , 2019, Photodiagnosis and photodynamic therapy.

[11]  M. Wainwright,et al.  Antimicrobial photodynamic therapy with phenothiazinium photosensitizers in non-vertebrate model Galleria mellonella infected with Fusarium keratoplasticum and Fusarium moniliforme. , 2019, Photodiagnosis and photodynamic therapy.

[12]  Z. Boucherit-Otmani,et al.  Effects of tyrosol and farnesol on Candida albicans biofilm , 2019, Molecular medicine reports.

[13]  E. Bresciani,et al.  Photodynamic inactivation of planktonic cultures and Streptococcus mutans biofilms for prevention of white spot lesions during orthodontic treatment: An in vitro investigation , 2019, American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics.

[14]  C. F. Rodrigues,et al.  Inflammatory Cell Recruitment in Candida glabrata Biofilm Cell-Infected Mice Receiving Antifungal Chemotherapy , 2019, Journal of clinical medicine.

[15]  M. Khoobi,et al.  Design and synthesis of mucoadhesive nanogel containing farnesol: investigation of the effect on HWP1, SAP6 and Rim101 genes expression of Candida albicans in vitro , 2019, Artificial cells, nanomedicine, and biotechnology.

[16]  A. Rizvi,et al.  ROS mediated antibacterial activity of photoilluminated riboflavin: A photodynamic mechanism against nosocomial infections , 2019, Toxicology reports.

[17]  C. F. Rodrigues,et al.  Candida sp. Infections in Patients with Diabetes Mellitus , 2019, Journal of clinical medicine.

[18]  Yichao Wu,et al.  A microfluidic gradient mixer‐flow chamber as a new tool to study biofilm development under defined solute gradients , 2018, Biotechnology and bioengineering.

[19]  J. Lopez-Ribot,et al.  Activity of anti-CR3-RP polyclonal antibody against biofilms formed by Candida auris, a multidrug-resistant emerging fungal pathogen , 2018, European Journal of Clinical Microbiology & Infectious Diseases.

[20]  Rong Wang.  Biofilms and Meat Safety: A Mini-Review. , 2019, Journal of food protection.

[21]  Simona Paulone,et al.  Anti-Candidaalbicans germ tube antibodies reduce in vitro growth and biofilm formation of C. albicans. , 2019, Revista iberoamericana de micologia.

[22]  C. F. Rodrigues,et al.  Promising alternative therapeutics for oral candidiasis. , 2019, Current medicinal chemistry.

[23]  K. Ledwoch,et al.  Candida auris Dry Surface Biofilm (DSB) for Disinfectant Efficacy Testing , 2018, Materials.

[24]  N. Gow,et al.  Single human B cell-derived monoclonal anti-Candida antibodies enhance phagocytosis and protect against disseminated candidiasis , 2018, Nature Communications.

[25]  A. Tedesco,et al.  Effect of Chloroaluminium phthalocyanine in cationic nanoemulsion on photoinactivation of multispecies biofilm. , 2018, Photodiagnosis and photodynamic therapy.

[26]  K. Takemoto,et al.  Efficacy of liposomal amphotericin B against four species of Candida biofilms in an experimental mouse model of intravascular catheter infection. , 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[27]  M. Papi,et al.  Graphene oxide coatings prevent Candida albicans biofilm formation with a controlled release of curcumin-loaded nanocomposites. , 2018, Nanomedicine.

[28]  E. Townsend,et al.  The comparative efficacy of antiseptics against Candida auris biofilms. , 2018, International journal of antimicrobial agents.

[29]  E. Bouza,et al.  The optimal ethanol lock therapy regimen for treatment of biofilm-associated catheter infections: an in-vitro study. , 2018, The Journal of hospital infection.

[30]  R. Prates,et al.  Controlling methylene blue aggregation: a more efficient alternative to treat Candida albicans infections using photodynamic therapy , 2018, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[31]  P. van Dijck,et al.  Fungal persister cells: The basis for recalcitrant infections? , 2018, PLoS pathogens.

[32]  R. J. Alves,et al.  Clioquinol is a promising preventive morphological switching compound in the treatment of Candida infections linked to the use of intrauterine devices , 2018, Journal of medical microbiology.

[33]  Mohammad Tahir Siddiqui,et al.  Antibiotics, Resistome and Resistance Mechanisms: A Bacterial Perspective , 2018, Front. Microbiol..

[34]  Shuna Fu,et al.  (1‐aryloxy‐2‐hydroxypropyl)‐phenylpiperazine derivatives suppress Candida albicans virulence by interfering with morphological transition , 2018, Microbial biotechnology.

[35]  D. Hogan,et al.  Role of quorum sensing and chemical communication in fungal biotechnology and pathogenesis , 2018, FEMS microbiology reviews.

[36]  S. Albers,et al.  Archaeal biofilm formation , 2018, Nature Reviews Microbiology.

[37]  A. Kalkancı,et al.  The in vitro effect of antimicrobial photodynamic therapy on Candida and Staphylococcus biofilms , 2018, Turkish journal of medical sciences.

[38]  S. Ranque,et al.  Oral fungal-bacterial biofilm models in vitro , 2018, Medical mycology.

[39]  M. Pourhajibagher,et al.  Antimicrobial Photodynamic Therapy: An Effective Alternative Approach to Control Bacterial Infections. , 2018, Journal of lasers in medical sciences.

[40]  Bailiang Wang,et al.  Recent developments in smart antibacterial surfaces to inhibit biofilm formation and bacterial infections. , 2018, Journal of materials chemistry. B.

[41]  R. Alasino,et al.  Silver Nanoparticles with High Loading Capacity of Amphotericin B: Characterization, Bactericidal and Antifungal Effects. , 2018, Current drug delivery.

[42]  S. Irusta,et al.  Evaluation of the Antimicrobial Activity and Cytotoxicity of Different Components of Natural Origin Present in Essential Oils , 2018, bioRxiv.

[43]  M. Ghannoum,et al.  In Vitro and In Vivo Activity of a Novel Catheter Lock Solution against Bacterial and Fungal Biofilms , 2018, Antimicrobial Agents and Chemotherapy.

[44]  C. F. Rodrigues,et al.  Portrait of Matrix Gene Expression in Candida glabrata Biofilms with Stress Induced by Different Drugs , 2018, Genes.

[45]  S. Garneau‐Tsodikova,et al.  Differential Effects of Linkers on the Activity of Amphiphilic Tobramycin Antifungals , 2018, Molecules.

[46]  I. Leonhardt,et al.  Farnesol signalling in Candida albicans – more than just communication , 2018, Critical reviews in microbiology.

[47]  S. Garneau‐Tsodikova,et al.  Novel fluconazole derivatives with promising antifungal activity. , 2017, Bioorganic & medicinal chemistry.

[48]  Alexander D. Johnson,et al.  Development and regulation of single- and multi-species Candida albicans biofilms , 2017, Nature Reviews Microbiology.

[49]  V. Lee,et al.  Cyclic‐di‐GMP regulation of virulence in bacterial pathogens , 2018, Wiley interdisciplinary reviews. RNA.

[50]  M. Jamal,et al.  Bacterial biofilm and associated infections. , 2018, Journal of the Chinese Medical Association : JCMA.

[51]  H. Bujdáková,et al.  The impact of farnesol in combination with fluconazole on Candida albicans biofilm: regulation of ERG20, ERG9, and ERG11 genes , 2018, Folia Microbiologica.

[52]  M. Costa,et al.  Photodynamic antimicrobial chemotherapy (PACT) using toluidine blue inhibits both growth and biofilm formation by Candida krusei , 2018, Lasers in Medical Science.

[53]  S. Hasnain,et al.  Biofilms: Survival and defense strategy for pathogens. , 2017, International journal of medical microbiology : IJMM.

[54]  M. Biswal,et al.  Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions. , 2017, The Journal of hospital infection.

[55]  C. F. Rodrigues,et al.  Liposomal and Deoxycholate Amphotericin B Formulations: Effectiveness against Biofilm Infections of Candida spp. , 2017, Pathogens.

[56]  M. Kühl,et al.  The Consequences of Being in an Infectious Biofilm: Microenvironmental Conditions Governing Antibiotic Tolerance , 2017, International journal of molecular sciences.

[57]  C. De Monte,et al.  Synthesis, biological evaluation and quantitative structure-active relationships of 1,3-thiazolidin-4-one derivatives. A promising chemical scaffold endowed with high antifungal potency and low cytotoxicity. , 2017, European journal of medicinal chemistry.

[58]  Felix Bongomin,et al.  Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision , 2017, Journal of fungi.

[59]  H. Bujdáková,et al.  Employment of methylene blue irradiated with laser light source in photodynamic inactivation of biofilm formed by Candida albicans strain resistant to fluconazole , 2017, Medical mycology.

[60]  K. Ishikawa,et al.  Cheese supplemented with probiotics reduced the Candida levels in denture wearers-RCT. , 2017, Oral diseases.

[61]  D. Monteiro,et al.  Antifungal activity of tyrosol and farnesol used in combination against Candida species in the planktonic state or forming biofilms , 2017, Journal of applied microbiology.

[62]  C. Rizzato,et al.  The synthetic killer peptide KP impairs Candida albicans biofilm in vitro , 2017, PloS one.

[63]  S. Garneau‐Tsodikova,et al.  Novel alkylated azoles as potent antifungals. , 2017, European journal of medicinal chemistry.

[64]  H. Shokri,et al.  Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV+ patients with candidiasis. , 2017, Journal de mycologie medicale.

[65]  H. Bujdáková,et al.  Properties and role of the quorum sensing molecule farnesol in relation to the yeast Candida albicans. , 2017, Die Pharmazie.

[66]  A. Chowdhary,et al.  Rapid and Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida auris , 2017, Journal of Clinical Microbiology.

[67]  Rony Noreldin,et al.  A pre-therapeutic coating for medical devices that prevents the attachment of Candida albicans , 2017, Annals of Clinical Microbiology and Antimicrobials.

[68]  M. Correia,et al.  Essential Oils from Leaves of Medicinal Plants of Brazilian Flora: Chemical Composition and Activity against Candida Species , 2017, Medicines.

[69]  S. Duarte,et al.  Effect of Photodynamic Antimicrobial Chemotherapy on Mono- and Multi-Species Cariogenic Biofilms: A Literature Review. , 2017, Photomedicine and laser surgery.

[70]  Young-Gyun Song,et al.  Inhibitory effects of Lactobacillus rhamnosus and Lactobacillus casei on Candida biofilm of denture surface. , 2017, Archives of oral biology.

[71]  L. Samaranayake,et al.  Future therapies targeted towards eliminating Candida biofilms and associated infections , 2017, Expert review of anti-infective therapy.

[72]  C. F. Rodrigues,et al.  Candida glabrata Biofilms: How Far Have We Come? , 2017, Journal of fungi.

[73]  Anand K. Ramasubramanian,et al.  The Candida albicans Biofilm Matrix: Composition, Structure and Function , 2017, Journal of fungi.

[74]  G. Beauchamp,et al.  Porcine Dendritic Cells as an In Vitro Model to Assess the Immunological Behaviour of Streptococcus suis Subunit Vaccine Formulations and the Polarizing Effect of Adjuvants , 2017, Pathogens.

[75]  C. F. Rodrigues,et al.  Candida Species Biofilms’ Antifungal Resistance , 2017, Journal of fungi.

[76]  L. Nahar,et al.  Aromatic Medicinal Plants of the Lamiaceae Family from Uzbekistan: Ethnopharmacology, Essential Oils Composition, and Biological Activities , 2017, Medicines.

[77]  M. Tonkić,et al.  Antimicrobial efficacy of probiotic-containing toothpastes: an in vitro evaluation. , 2017, Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina.

[78]  S. Kokate,et al.  Evaluation of the Role of Probiotics in Endodontic Treatment: A Preliminary Study , 2017, Journal of International Society of Preventive & Community Dentistry.

[79]  J. C. Junqueira,et al.  Lactobacillus rhamnosus inhibits Candida albicans virulence factors in vitro and modulates immune system in Galleria mellonella , 2017, Journal of applied microbiology.

[80]  C. F. Rodrigues,et al.  Oral mucositis caused by Candida glabrata biofilms: failure of the concomitant use of fluconazole and ascorbic acid , 2017, Therapeutic advances in infectious disease.

[81]  F. Villa,et al.  Coating polypropylene surfaces with protease weakens the adhesion and increases the dispersion of Candida albicans cells , 2017, Biotechnology Letters.

[82]  S. R. de Almeida,et al.  An In Vitro Model for the Study of the Macrophage Response Upon Trichophyton rubrum Challenge , 2016, Mycopathologia.

[83]  A. O. Jorge,et al.  Lactobacillus is able to alter the virulence and the sensitivity profile of Candida albicans , 2016, Journal of applied microbiology.

[84]  G. Olveira,et al.  An update on probiotics, prebiotics and symbiotics in clinical nutrition. , 2016, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

[85]  K. Konopka,et al.  Cationic porphyrin-mediated photodynamic inactivation of Candida biofilms and the effect of miconazole. , 2016, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[86]  F. Scannapieco,et al.  Oral inflammation and infection, and chronic medical diseases: implications for the elderly. , 2016, Periodontology 2000.

[87]  C. Marques,et al.  Interaction of Staphylococcus aureus persister cells with the host when in a persister state and following awakening , 2016, Scientific Reports.

[88]  Samuel A. Lee,et al.  An Optimized Lock Solution Containing Micafungin, Ethanol and Doxycycline Inhibits Candida albicans and Mixed C. albicans – Staphyloccoccus aureus Biofilms , 2016, PloS one.

[89]  J. Fu,et al.  In vitro inhibitory activity of probiotic products against oral Candida species , 2016, Journal of applied microbiology.

[90]  Yang Liang,et al.  Mechanical properties of the superficial biofilm layer determine the architecture of biofilms. , 2016, Soft matter.

[91]  Ronald N. Jones,et al.  Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates , 2016, The Journal of antimicrobial chemotherapy.

[92]  V. Pardi,et al.  In Vitro and In Vivo Antifungal Activity of Lichochalcone-A against Candida albicans Biofilms , 2016, PloS one.

[93]  M. Jabra-Rizk,et al.  Pathogenesis of Candida albicans biofilm. , 2016, Pathogens and disease.

[94]  N. Martins,et al.  In vitro anti-Candida activity of Glycyrrhiza glabra L. , 2016 .

[95]  L. Samaranayake,et al.  Probiotics as Antifungals in Mucosal Candidiasis. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[96]  S. Tandon,et al.  Antimicrobial Efficacy of Probiotic and Herbal Oral Rinses against Candida albicans in Children: A Randomized Clinical Trial , 2016, International journal of clinical pediatric dentistry.

[97]  J. Gunn,et al.  What's on the Outside Matters: The Role of the Extracellular Polymeric Substance of Gram-negative Biofilms in Evading Host Immunity and as a Target for Therapeutic Intervention* , 2016, The Journal of Biological Chemistry.

[98]  L. Samaranayake,et al.  Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation , 2016, Applied Microbiology and Biotechnology.

[99]  K. Sauer,et al.  Escaping the biofilm in more than one way: desorption, detachment or dispersion. , 2016, Current opinion in microbiology.

[100]  J. Burton,et al.  Inhibition of Candida albicans biofilm formation and modulation of gene expression by probiotic cells and supernatant. , 2016, Journal of medical microbiology.

[101]  Soni Kottayi,et al.  Comparison of Antimicrobial Activity of Chlorhexidine, Coconut Oil, Probiotics, and Ketoconazole on Candida albicans Isolated in Children with Early Childhood Caries: An In Vitro Study , 2016, Scientifica.

[102]  J. Lin,et al.  Farnesol, a sesquiterpene alcohol in essential oils, ameliorates serum allergic antibody titres and lipid profiles in ovalbumin-challenged mice. , 2016, Allergologia et immunopathologia.

[103]  J. Nett.  The Host’s Reply to Candida Biofilm , 2016, Pathogens.

[104]  J. Sobel,et al.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[105]  H. Bujdáková.  Management of Candida biofilms: state of knowledge and new options for prevention and eradication. , 2016, Future microbiology.

[106]  C. Seneviratne,et al.  Combining prebiotics and probiotics to develop novel synbiotics that suppress oral pathogens , 2016 .

[107]  A. Tosetto,et al.  Comparison between different D‐Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study , 2016, International journal of laboratory hematology.

[108]  C. Seneviratne,et al.  Therapeutic Application of Synbiotics, a Fusion of Probiotics and Prebiotics, and Biogenics as a New Concept for Oral Candida Infections: A Mini Review , 2016, Front. Microbiol..

[109]  N. C. Silva,et al.  New Eugenol Glucoside‐based Derivative Shows Fungistatic and Fungicidal Activity against Opportunistic Candida glabrata , 2016, Chemical biology & drug design.

[110]  A. Rodrigues,et al.  In vitro antifungal activity and in vivo antibiofilm activity of cerium nitrate against Candida species. , 2015, The Journal of antimicrobial chemotherapy.

[111]  P. Pappas,et al.  Invasive Candidiasis. , 2016, Infectious disease clinics of North America.

[112]  A. Ishijima,et al.  Prophylactic Effect of Lactobacillus pentosus strain S-PT84 on Candida Infection and Gastric Inflammation in a Murine Gastrointestinal Candidiasis Model [Errata]. , 2016, Medical mycology journal.

[113]  P. Cosette,et al.  Proteomics dedicated to biofilmology: What have we learned from a decade of research? , 2016, Medical Microbiology and Immunology.

[114]  B. Berger,et al.  High prevalence of colonization of oral cavity by respiratory pathogens in frail older patients with oropharyngeal dysphagia , 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[115]  K. Sauer,et al.  Control of Biofilms with the Fatty Acid Signaling Molecule cis-2-Decenoic Acid , 2015, Pharmaceuticals.

[116]  Alexander D. Johnson,et al.  Candida albicans Biofilms and Human Disease. , 2015, Annual review of microbiology.

[117]  R. Rajendran,et al.  New strategic insights into managing fungal biofilms , 2015, Front. Microbiol..

[118]  L. C. Malaquias,et al.  Synthesis and Biological Evaluation of New Eugenol Mannich Bases as Promising Antifungal Agents , 2015, Chemical biology & drug design.

[119]  J. Ling,et al.  Synergistic effects of tea catechin epigallocatechin gallate and antimycotics against oral Candida species. , 2015, Archives of oral biology.

[120]  H. Bujdáková,et al.  Effectiveness of the Photoactive Dye Methylene Blue versus Caspofungin on the Candida parapsilosis Biofilm in vitro and ex vivo , 2015, Photochemistry and photobiology.

[121]  C. Spagnul,et al.  Immobilized photosensitizers for antimicrobial applications. , 2015, Journal of photochemistry and photobiology. B, Biology.

[122]  Hongmei Zhou,et al.  Inhibitory effects of oral Actinomyces on the proliferation, virulence and biofilm formation of Candida albicans. , 2015, Archives of oral biology.

[123]  D. M. Lynn,et al.  Antifungal Activity of 14-Helical β-Peptides against Planktonic Cells and Biofilms of Candida Species , 2015, Pharmaceuticals.

[124]  J. Lopez-Ribot,et al.  A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance , 2015, npj Biofilms and Microbiomes.

[125]  S. Twetman,et al.  Effect of Probiotic Bacteria on Oral Candida in Frail Elderly , 2015, Journal of dental research.

[126]  D. Greetham,et al.  Acetylcholine Protects against Candida albicans Infection by Inhibiting Biofilm Formation and Promoting Hemocyte Function in a Galleria mellonella Infection Model , 2015, Eukaryotic Cell.

[127]  B. Posteraro,et al.  Antifungal drug resistance among Candida species: mechanisms and clinical impact , 2015, Mycoses.

[128]  N. Kottegoda,et al.  Slow release anti-fungal skin formulations based on citric acid intercalated layered double hydroxides nanohybrids , 2015, Chemistry Central Journal.

[129]  Ana Maria Carvalho,et al.  Plants used in folk medicine: The potential of their hydromethanolic extracts against Candida species , 2015 .

[130]  E. G. Silva,et al.  A multispecies probiotic reduces oral Candida colonization in denture wearers. , 2015, Journal of prosthodontics : official journal of the American College of Prosthodontists.

[131]  Kerstin Hünniger,et al.  Host response to Candida albicans bloodstream infection and sepsis , 2015, Virulence.

[132]  P. Caufield,et al.  Oral Lactobacilli and Dental Caries , 2015, Journal of dental research.

[133]  M. Hamid,et al.  In vitro anti-yeast activity of chloramphenicol: A preliminary report. , 2015, Journal de mycologie medicale.

[134]  N. Martins,et al.  Evaluation of bioactive properties and phenolic compounds in different extracts prepared from Salvia officinalis L. , 2015, Food chemistry.

[135]  B. Kumar,et al.  Asarones from Acorus calamus in Combination with Azoles and Amphotericin B: A Novel Synergistic Combination to Compete Against Human Pathogenic Candida Species In Vitro , 2015, Applied Biochemistry and Biotechnology.

[136]  D. Stien,et al.  Antibacterial ilicicolinic acids C and D and ilicicolinal from Neonectria discophora SNB-CN63 isolated from a termite nest. , 2015, Journal of natural products.

[137]  G. Braus,et al.  One Juliet and four Romeos: VeA and its methyltransferases , 2015, Front. Microbiol..

[138]  J. D. Santos,et al.  Lactobacillus acidophilus ATCC 4356 inhibits biofilm formation by C. albicans and attenuates the experimental candidiasis in Galleria mellonella , 2015, Virulence.

[139]  David W Williams,et al.  Virulence and pathogenicity of Candida albicans is enhanced in biofilms containing oral bacteria , 2015, Biofouling.

[140]  S. Filler,et al.  Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue. , 2015, Microbiology.

[141]  A. Rodrigues,et al.  In vitro antifungal activity and in vivo antibiofilm activity of cerium nitrate against Candida species. , 2015, The Journal of antimicrobial chemotherapy.

[142]  S. Milewski,et al.  Essential Oils, Silver Nanoparticles and Propolis as Alternative Agents Against Fluconazole Resistant Candida albicans, Candida glabrata and Candida krusei Clinical Isolates , 2014, Indian Journal of Microbiology.

[143]  C. H. Camargo,et al.  Candida species biofilm and Candida albicans ALS3 polymorphisms in clinical isolates , 2014, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[144]  Alexander D. Johnson,et al.  Mucins Suppress Virulence Traits of Candida albicans , 2014, mBio.

[145]  C. G. Diniz,et al.  Synthesis and biological evaluation of a new series of N-acyldiamines as potential antibacterial and antifungal agents. , 2014, Bioorganic & medicinal chemistry letters.

[146]  H. Sanchez,et al.  Rat Indwelling Urinary Catheter Model of Candida albicans Biofilm Infection , 2014, Infection and Immunity.

[147]  E. Mellado,et al.  Current status of antifungal resistance and its impact on clinical practice , 2014, British journal of haematology.

[148]  N. Alitheen,et al.  Probiotic Potential of Lactobacillus Strains with Antimicrobial Activity against Some Human Pathogenic Strains , 2014, BioMed research international.

[149]  J. Dogné,et al.  Erratum to “Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants” , 2014, BioMed research international.

[150]  P. Mishra,et al.  Isolation of a new broad spectrum antifungal polyene from Streptomyces sp. MTCC 5680 , 2014, Letters in applied microbiology.

[151]  M. J. Cocero,et al.  Encapsulation and Co-Precipitation Processes with Supercritical Fluids:Applications with Essential Oils , 2014 .

[152]  B. Peters,et al.  Candida Vaginitis: When Opportunism Knocks, the Host Responds , 2014, PLoS pathogens.

[153]  V. Aleksić,et al.  Antimicrobial and antioxidative activity of extracts and essential oils of Myrtus communis L. , 2014, Microbiological research.

[154]  C. Vergani,et al.  Candida albicans adherence to an acrylic resin modified by experimental photopolymerised coatings: an in vitro study. , 2014, Gerodontology.

[155]  Hongmei Zhou,et al.  Efficacy and safety of probiotics in the treatment of Candida‐associated stomatitis , 2014, Mycoses.

[156]  W. Bowen,et al.  Symbiotic Relationship between Streptococcus mutans and Candida albicans Synergizes Virulence of Plaque Biofilms In Vivo , 2014, Infection and Immunity.

[157]  S. J. Park,et al.  Influence of Bacterial Presence on Biofilm Formation of Candida albicans , 2014, Yonsei medical journal.

[158]  S. Srivastava,et al.  Anti-Candida activity of two-peptide bacteriocins, plantaricins (Pln E/F and J/K) and their mode of action. , 2014, Fungal biology.

[159]  Shaun Robertson,et al.  Strength in numbers: antifungal strategies against fungal biofilms. , 2014, International journal of antimicrobial agents.

[160]  J. T. ten Cate,et al.  Candida and Other Fungal Species , 2014, Journal of dental research.

[161]  V. K. Bari,et al.  Sphingolipid Biosynthetic Pathway Genes FEN1 and SUR4 Modulate Amphotericin B Resistance , 2014, Antimicrobial Agents and Chemotherapy.

[162]  L. Espindola,et al.  Antimicrobial and cytotoxic secondary metabolites from tropical leaf endophytes: Isolation of antibacterial agent pyrrocidine C from Lewia infectoria SNB-GTC2402. , 2013, Phytochemistry.

[163]  A. Vilcinskas,et al.  Myriocin Significantly Increases the Mortality of a Non-Mammalian Model Host during Candida Pathogenesis , 2013, PloS one.

[164]  M. Jayashree,et al.  Probiotic Use and Prevalence of Candidemia and Candiduria in a PICU , 2013, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[165]  P. van Dijck,et al.  Recent insights into Candida albicans biofilm resistance mechanisms , 2013, Current Genetics.

[166]  G. Campus,et al.  The Use of Probiotic Strains in Caries Prevention: A Systematic Review , 2013, Nutrients.

[167]  M. Najafi,et al.  Traditional and Modern Uses of Natural Honey in Human Diseases: A Review , 2013, Iranian journal of basic medical sciences.

[168]  G. Demirel,et al.  Prophylactic Saccharomyces boulardii versus nystatin for the prevention of fungal colonization and invasive fungal infection in premature infants , 2013, European Journal of Pediatrics.

[169]  D. Stien,et al.  Antifungal agents from Pseudallescheria boydii SNB-CN73 isolated from a Nasutitermes sp. termite. , 2013, Journal of natural products.

[170]  Nicholas J. Jacobs,et al.  Control of Candida albicans Metabolism and Biofilm Formation by Pseudomonas aeruginosa Phenazines , 2013, mBio.

[171]  M. Taleb,et al.  Assessment of the types of catheter infectivity caused by Candida species and their biofilm formation. First study in an intensive care unit in Algeria , 2013, International journal of general medicine.

[172]  David W Williams,et al.  Interactions of Candida albicans with host epithelial surfaces , 2013, Journal of oral microbiology.

[173]  Craig Williams,et al.  The clinical importance of fungal biofilms. , 2013, Advances in applied microbiology.

[174]  R. Cordeiro,et al.  Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol. , 2013, Medical mycology.

[175]  A. Fusco-Almeida,et al.  Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. , 2013, Journal of medical microbiology.

[176]  P. Lingström,et al.  Fermentation of sugars and sugar alcohols by plaque Lactobacillus strains , 2013, Clinical Oral Investigations.

[177]  M. Otto,et al.  Molecular basis of in vivo biofilm formation by bacterial pathogens. , 2012, Chemistry & biology.

[178]  David W. Denning,et al.  Hidden Killers: Human Fungal Infections , 2012, Science Translational Medicine.

[179]  A. O. Jorge,et al.  Effects of probiotic bacteria on Candida presence and IgA anti-Candida in the oral cavity of elderly. , 2012, Brazilian dental journal.

[180]  G. Reid,et al.  Probiotic Interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the Opportunistic Fungal Pathogen Candida albicans , 2012, Infectious diseases in obstetrics and gynecology.

[181]  J. Begović,et al.  Probiotic features of two oral Lactobacillus isolates , 2012, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[182]  Arturo Casadevall,et al.  Quorum sensing in fungi--a review. , 2012, Medical mycology.

[183]  C. R. Paula,et al.  Treatment with probiotics in experimental oral colonization by Candida albicans in murine model (DBA/2). , 2012, Oral diseases.

[184]  Shabana I. Khan,et al.  Synthesis and Biological Evaluation of Some Hydrazone Derivatives as Anti-inflammatory Agents , 2012 .

[185]  J. Bagg,et al.  Carbohydrate Derived Fulvic Acid: An in vitro Investigation of a Novel Membrane Active Antiseptic Agent Against Candida albicans Biofilms , 2012, Front. Microbio..

[186]  A. Dicko,et al.  The Therapeutic Benefits of Essential Oils , 2012 .

[187]  Michael R Hamblin,et al.  Concepts and Principles of Photodynamic Therapy as an Alternative Antifungal Discovery Platform , 2012, Front. Microbio..

[188]  A. Gonçalves,et al.  The Prevalence of Urogenital Infections in Pregnant Women Experiencing Preterm and Full-Term Labor , 2012, Infectious diseases in obstetrics and gynecology.

[189]  Zhihong Xie,et al.  Synergistic Interaction between Candida albicans and Commensal Oral Streptococci in a Novel In Vitro Mucosal Model , 2011, Infection and Immunity.

[190]  M. Ghannoum,et al.  Lipidomics of Candida albicans biofilms reveals phase-dependent production of phospholipid molecular classes and role for lipid rafts in biofilm formation. , 2011, Microbiology.

[191]  Punita Sharma,et al.  In vitro antifungal activities of amphotericin B in combination with acteoside, a phenylethanoid glycoside from Colebrookea oppositifolia. , 2011, Journal of medical microbiology.

[192]  N. Oberlies,et al.  Synergy-directed fractionation of botanical medicines: a case study with goldenseal (Hydrastis canadensis). , 2011, Journal of natural products.

[193]  M. Bodinier,et al.  Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions , 2011, Journal of leukocyte biology.

[194]  P. Fidel,et al.  Candida-Host Interactions in HIV Disease , 2011, Advances in dental research.

[195]  R. Rajendran,et al.  Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[196]  T. Tolker-Nielsen,et al.  The implication of Pseudomonas aeruginosa biofilms in infections. , 2011, Inflammation & allergy drug targets.

[197]  X. Feás,et al.  Antifungal effect of lavender honey against Candida albicans, Candida krusei and Cryptococcus neoformans , 2011, Journal of food science and technology.

[198]  A. Mitchell,et al.  Genetic control of Candida albicans biofilm development , 2011, Nature Reviews Microbiology.

[199]  David W Williams,et al.  Pathogenesis and treatment of oral candidosis , 2011, Journal of oral microbiology.

[200]  R. Knight,et al.  Microbiota restoration: natural and supplemented recovery of human microbial communities , 2011, Nature Reviews Microbiology.

[201]  V. Bisaria,et al.  Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes , 2010, BMC Genomics.

[202]  E. Behzadi,et al.  Urinary Tract Infections Associated with Candida albicans. , 2010, Maedica.

[203]  M. Harriott,et al.  Candida albicans forms biofilms on the vaginal mucosa , 2010, Microbiology.

[204]  David Hernández,et al.  Study of inter- and intra-individual variations in the salivary microbiota , 2010, BMC Genomics.

[205]  P. Pappas.  Opportunistic Fungi: A View to the Future , 2010, The American journal of the medical sciences.

[206]  A. Haukioja.  Probiotics and Oral Health , 2010, European journal of dentistry.

[207]  Z. Al-Dwairi,et al.  The relationship between tobacco smoking and oral colonization with Candida species. , 2010, The journal of contemporary dental practice.

[208]  A. Ouwehand,et al.  Human intestinal microbiota and healthy ageing , 2010, Ageing Research Reviews.

[209]  V. Bagnato,et al.  Photodynamic inactivation of four Candida species induced by photogem® , 2010, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[210]  J. Kaplan,et al.  Biofilm Dispersal: Mechanisms, Clinical Implications, and Potential Therapeutic Uses , 2010, Journal of dental research.

[211]  K. Bhat,et al.  Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial , 2010, Journal of oral microbiology.

[212]  D. Kaushik,et al.  PHARMACOLOGICAL POTENTIAL OF MATRICARIA RECUTITA-A REVIEW , 2010 .

[213]  N. Silva,et al.  Biological properties of medicinal plants: a review of their antimicrobial activity , 2010 .

[214]  Jordi Rello,et al.  International study of the prevalence and outcomes of infection in intensive care units. , 2009, JAMA.

[215]  K. Sauer,et al.  A Novel Signaling Network Essential for Regulating Pseudomonas aeruginosa Biofilm Development , 2009, PLoS pathogens.

[216]  J. Costerton,et al.  Periodontitis: an archetypical biofilm disease. , 2009, Journal of the American Dental Association.

[217]  C. Lass‐Flörl.  The changing face of epidemiology of invasive fungal disease in Europe , 2009, Mycoses.

[218]  R. Meijering,et al.  Farnesol-Induced Apoptosis in Candida albicans , 2009, Antimicrobial Agents and Chemotherapy.

[219]  D. Davies,et al.  A Fatty Acid Messenger Is Responsible for Inducing Dispersion in Microbial Biofilms , 2008, Journal of bacteriology.

[220]  J. Štětina,et al.  Production of organic acids by Lactobacillus strains in three different media , 2009 .

[221]  Barış Derya Erçal,et al.  Antifungal activity of Turkish honey against Candida spp. and Trichosporon spp: an in vitro evaluation. , 2009, Medical mycology.

[222]  J. Kerrigan,et al.  Modeling and biochemical analysis of the activity of antibiofilm agent Dispersin B. , 2008, Acta biologica Hungarica.

[223]  G. Tetz,et al.  Effect of DNase and Antibiotics on Biofilm Characteristics , 2008, Antimicrobial Agents and Chemotherapy.

[224]  Ermelinda Pereira,et al.  Antioxidant and antimicrobial effects of phenolic compounds extracts of Northeast Portugal honey. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[225]  S. H. Alves,et al.  In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp. , 2008, Canadian journal of microbiology.

[226]  M. Chandrasekaran,et al.  Antifungal Activity of Plant Extracts against Candida Species from Oral Lesions , 2008, Indian journal of pharmaceutical sciences.

[227]  A. Molassiotis,et al.  A systematic review of honey uses and its potential value within oncology care. , 2008, Journal of clinical nursing.

[228]  Zhibing Zhang,et al.  Bacterial adhesion and biofilms on surfaces , 2008 .

[229]  T. Patterson,et al.  Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection , 2008, Antimicrobial Agents and Chemotherapy.

[230]  L. Hammarström,et al.  Characterization of oral lactobacilli as potential probiotics for oral health. , 2008, Oral microbiology and immunology.

[231]  M. Fleischhacker,et al.  Secretion of E,E-Farnesol and Biofilm Formation in Eight Different Candida Species , 2008, Antimicrobial Agents and Chemotherapy.

[232]  Laid Boukraa,et al.  Ação sinergística de amido e mel sobre Cândida albicans em relação ao índice de diastase , 2008 .

[233]  L. Boukraâ,et al.  Synergistic action of starch and honey against Candida albicans in correlation with diastase number , 2008, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[234]  V. Fowler,et al.  Candida infective endocarditis , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[235]  M. Sanders.  Probiotics: definition, sources, selection, and uses. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[236]  K. Lewis.  Multidrug tolerance of biofilms and persister cells. , 2008, Current topics in microbiology and immunology.

[237]  L. Pascual,et al.  Purification and Partial Characterization of Novel Bacteriocin L23 Produced by Lactobacillusfermentum L23 , 2008, Current Microbiology.

[238]  R. Korpela,et al.  Probiotics Reduce the Prevalence of Oral Candida in the Elderly—a Randomized Controlled Trial , 2007, Journal of dental research.

[239]  L. Monnens,et al.  Fungal peritonitis in children on peritoneal dialysis , 2007, Pediatric Nephrology.

[240]  M. Pfaller,et al.  Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem , 2007, Clinical Microbiology Reviews.

[241]  Murat Küçük,et al.  Biological activities and chemical composition of three honeys of different types from Anatolia , 2007 .

[242]  Manickkam Jayakumar,et al.  In vitro antibacterial activity of some plant essential oils , 2006, BMC complementary and alternative medicine.

[243]  J. Hacker,et al.  Inactivation of the phospholipase B gene PLB5 in wild-type Candida albicans reduces cell-associated phospholipase A2 activity and attenuates virulence. , 2006, International journal of medical microbiology : IJMM.

[244]  Mohammed D Y Oteef,et al.  Production of Tyrosol by Candida albicans Biofilms and Its Role in Quorum Sensing and Biofilm Development , 2006, Eukaryotic Cell.

[245]  M. Falagas,et al.  Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. , 2006, The Journal of antimicrobial chemotherapy.

[246]  D. Carter,et al.  Honey has an antifungal effect against Candida species. , 2006, Medical mycology.

[247]  J. Lawson,et al.  In vitro modulation of inflammatory cytokine and IgG levels by extracts of Perna canaliculus , 2006, BMC complementary and alternative medicine.

[248]  Å. Nilsson,et al.  Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. , 2006, Swedish dental journal.

[249]  A. G. Wondra,et al.  Comparison of extracts prepared from plant by-products using different solvents and extraction time , 2005 .

[250]  J. Wilkinson,et al.  Bactericidal activity of different honeys against pathogenic bacteria. , 2005, Archives of medical research.

[251]  Victoria J. Fraser,et al.  Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality , 2005, Antimicrobial Agents and Chemotherapy.

[252]  S. Elahi,et al.  Enhanced clearance of Candida albicans from the oral cavities of mice following oral administration of Lactobacillus acidophilus , 2005, Clinical and experimental immunology.

[253]  David W. Johnson,et al.  Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. , 2005, Journal of the American Society of Nephrology : JASN.

[254]  J. Lopez-Ribot,et al.  Candida Biofilms: an Update , 2005, Eukaryotic Cell.

[255]  K. Abu-Elteen.  The influence of dietary carbohydrates on in vitro adherence of four Candida species to human buccal epithelial cells , 2005 .

[256]  Paul Stoodley,et al.  Biofilm formation and dispersal and the transmission of human pathogens. , 2005, Trends in microbiology.

[257]  J. Konopka,et al.  Lipid Raft Polarization Contributes to Hyphal Growth in Candida albicans , 2004, Eukaryotic Cell.

[258]  G. Fink,et al.  Tyrosol is a quorum-sensing molecule in Candida albicans. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[259]  R. Darouiche,et al.  Candida Infections of Medical Devices , 2004, Clinical Microbiology Reviews.

[260]  Paul Stoodley,et al.  Bacterial biofilms: from the Natural environment to infectious diseases , 2004, Nature Reviews Microbiology.

[261]  F. Reiss,et al.  Immunological studies of the anticryptococcal factor of normal human serum , 1975, Mycopathologia.

[262]  D. Hoover,et al.  Bacteriocins and their Food Applications. , 2003, Comprehensive reviews in food science and food safety.

[263]  L. J. Douglas,et al.  Candida biofilms and their role in infection. , 2003, Trends in microbiology.

[264]  B. Wickes,et al.  Inhibition of Candida albicans Biofilm Formation by Farnesol, a Quorum-Sensing Molecule , 2002, Applied and Environmental Microbiology.

[265]  J. Costerton,et al.  Biofilms as complex differentiated communities. , 2002, Annual review of microbiology.

[266]  J. Staab,et al.  Reevaluation of the Role of HWP1 in Systemic Candidiasis by Use of Candida albicans Strains with Selectable Marker URA3 Targeted to the ENO1 Locus , 2002, Infection and Immunity.

[267]  Yung-Hua Li,et al.  A Quorum-Sensing Signaling System Essential for Genetic Competence in Streptococcus mutans Is Involved in Biofilm Formation , 2002, Journal of bacteriology.

[268]  H. Kuramitsu,et al.  Genetic exchange between Treponema denticola and Streptococcus gordonii in biofilms. , 2002, Oral microbiology and immunology.

[269]  J. Costerton,et al.  Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Clinical Microbiology Reviews.

[270]  H. C. van der Mei,et al.  Comparison of the Microbial Composition of Voice Prosthesis Biofilms from Patients Requiring Frequent versus Infrequent Replacement , 2002, The Annals of otology, rhinology, and laryngology.

[271]  J. Mattick,et al.  Extracellular DNA required for bacterial biofilm formation. , 2002, Science.

[272]  J. Costerton,et al.  Pseudomonas aeruginosa Displays Multiple Phenotypes during Development as a Biofilm , 2002, Journal of bacteriology.

[273]  S. Grobler,et al.  The antifungal action of three South African honeys on Candida albicans , 2001 .

[274]  R. Calderone,et al.  Virulence factors of Candida albicans. , 2001, Trends in microbiology.

[275]  K. Nickerson,et al.  Quorum Sensing in the Dimorphic FungusCandida albicans Is Mediated by Farnesol , 2001, Applied and Environmental Microbiology.

[276]  P. Molan.  Why honey is effective as a medicine , 2001 .

[277]  Matthew R. Parsek,et al.  Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms , 2000, Nature.

[278]  W. Hammes,et al.  Characterization of Reutericyclin Produced by Lactobacillus reuteri LTH2584 , 2000, Applied and Environmental Microbiology.

[279]  N. Rege,et al.  PHARMACOLOGY OF MEDICINAL PLANTS AND NATURAL PRODUCTS , 2000 .

[280]  A. Brooun,et al.  A Dose-Response Study of Antibiotic Resistance inPseudomonas aeruginosa Biofilms , 2000, Antimicrobial Agents and Chemotherapy.

[281]  H. J. Dorman,et al.  Antimicrobial agents from plants: antibacterial activity of plant volatile oils , 2000, Journal of applied microbiology.

[282]  M. Sawamura.  Aroma and functional properties of Japanese yuzu (Citrus junos Tanaka) essential oil. , 2000 .

[283]  G. Pizzo,et al.  Effect of dietary carbohydrates on the in vitro epithelial adhesion of Candida albicans, Candida tropicalis, and Candida krusei. , 2000, The new microbiologica.

[284]  S. Huraib,et al.  Manuka Honey for Central Vein Catheter Exit Site Care , 1999 .

[285]  H. Odendaal,et al.  Characterization of pentocin TV35b, a bacteriocin‐like peptide isolated from Lactobacillus pentosus with a fungistatic effect on Candida albicans , 1999, Journal of applied microbiology.

[286]  S. Gorman,et al.  Detection of Prosthetic Hip Infection at Revision Arthroplasty by Immunofluorescence Microscopy and PCR Amplification of the Bacterial 16S rRNA Gene , 1999, Journal of Clinical Microbiology.

[287]  M. M. Cowan.  Plant Products as Antimicrobial Agents , 1999, Clinical Microbiology Reviews.

[288]  J. Costerton,et al.  Bacterial biofilms: a common cause of persistent infections. , 1999, Science.

[289]  M. Ghannoum,et al.  Cloning and Disruption of caPLB1, a Phospholipase B Gene Involved in the Pathogenicity of Candida albicans * , 1998, The Journal of Biological Chemistry.

[290]  M. Meyer,et al.  Dental plaque, platelets, and cardiovascular diseases. , 1998, Annals of periodontology.

[291]  M. Wainwright,et al.  Photodynamic antimicrobial chemotherapy (PACT). , 1998, Journal of Antimicrobial Chemotherapy.

[292]  Roberto Kolter,et al.  Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis , 1998, Molecular microbiology.

[293]  C. Pérez-Giraldo,et al.  Phagocytosis and killing of slime-producing Staphylococcus epidermidis bypolymorphonuclear leukocytes. Effects of sparfloxacin. , 1998, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

[294]  M. Hilty,et al.  Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice , 1997, Infection and immunity.

[295]  P. Stewart,et al.  Theoretical aspects of antibiotic diffusion into microbial biofilms , 1996, Antimicrobial agents and chemotherapy.

[296]  D. Stickler,et al.  Bacterial biofilms and the encrustation of urethral catheters , 1996 .

[297]  G R Gibson,et al.  Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. , 1995, The Journal of nutrition.

[298]  C. Olliff,et al.  The effects of extracellular slime from Staphylococcus epidermidis on phagocytic ingestion and killing. , 1994, FEMS immunology and medical microbiology.

[299]  A. Kharazmi,et al.  Complement activation by Pseudomonas aeruginosa biofilms. , 1993, Microbial pathogenesis.

[300]  L. Axelsson,et al.  In Vitro Studies on Reuterin Synthesis by Lactobacillus reuteri , 2009 .

[301]  L. Axelsson,et al.  In VitroStudies on Reuterin Synthesis byLactobacillus reuteri , 1989 .

[302]  R. Fuller,et al.  Probiotics in man and animals. , 1989, The Journal of applied bacteriology.

[303]  I. Casas,et al.  Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri , 1988, Antimicrobial Agents and Chemotherapy.

[304]  J. Costerton,et al.  Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis. , 1985, The Journal of bone and joint surgery. American volume.

[305]  J M Jay,et al.  Antimicrobial properties of diacetyl , 1982, Applied and environmental microbiology.

[306]  A. Scheinin,et al.  Turku sugar studies. VIII. Principal microbiological findings. , 1976, Acta odontologica Scandinavica.

[307]  A. Scheinin,et al.  Turku sugar studies. III. An intermediate report on the effect of sucrose, fructose and xylitol diets on the numbers of salivary lactobacilli, candida and streptococci. , 1974, Acta odontologica Scandinavica.

[308]  J. van Houte,et al.  Ecology of Human Oral Lactobacilli , 1972, Infection and immunity.